معرفی
Dr Orin Chisholm is a program director at the Sydney Pharmacy School (University of Sydney), an Adjunct Associate Professor at UNSW Sydney, and teaches at Arizona State University. Her work focuses on regulatory science, pharmaceutical policy, and capacity-building in the therapeutics industry.
- BSc (Hons) in Biochemistry, University of Sydney
- PhD in Molecular Biology, University of Sydney
- Graduate Certificate in University Learning and Teaching, UNSW Sydney
Her research explores regulatory frameworks for emerging therapeutics, horizon scanning of medical technologies, and competency-based education in pharmaceutical sciences. Recent projects include NHMRC Partnership Grant (2025-2028) for horizon scanning and national medicines policy reviews.
Her publications analyze regulatory reforms, benefit-risk methodologies, and educational transformations in pharmaceutical medicine. Key themes include precision medicine, clinical research, and medical device regulation.
- TOPRA Award for Excellence in Regulatory Education (2017)
- Senior Fellow of the Higher Education Academy (SFHEA) (2018)
- Fellow of the Regulatory Affairs Professionals Society (FRAPS) (2021)
- Fellow of ARCS Australia (FMPP) (2025)
She supervises higher-degree research students, including Owen Smith (AAV gene therapies) and Matthew Britland (Medical Affairs and Quality Use of Medicines). Grants include funding for nanoparticle immunotherapy platforms and peptide-drug conjugate manufacturing.
